Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Saturday, July 13, 2024 | Back issues
Courthouse News Service Courthouse News Service

Diabetes Drugs

A federal court in New York dismissed all but one claim against a pharmaceutical company in a suit claiming it inflated the prices of two diabetes drugs. The purchasers monopoly claims may continue, but their antitrust claims fail. 

NEW YORK – A federal court in New York dismissed all but one claim against a pharmaceutical company in a suit claiming it inflated the prices of two diabetes drugs. The purchasers' monopoly claims may continue, but their antitrust claims fail. 

Categories / Business, Consumers

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...